Maryland Invests $500k in Cytomedix Orthopedic Device Company

Share on Facebook
Maryland Venture Fund has invested $500,000 in Gaithersburg, Md.-based Cytomedix, a regenerative medicine company currently focused on its AutoloGel System for using platelet-rich plasma to heal wounds, according to Maryland Business News.

The investment is through the state's Maryland Department of Business and Economic Development InvestMaryland program. Cytomedix is working on a $27.5 million capital campaign, and is looking to add 13 employees and increase worldwide marketing, according to the report.

In addition to the AutologGel System, Cytomedix produces the Angel Whole Blood Separation System for orthopedic and surgical uses.

More Articles on Supply Chain:
OrthoData Receives $250k Investment for Developing Spine Technologies
Stryker Unveiled Iconix All Suture Device for Shoulder, Hip Arthroscopy
Biomaterials Market Estimated at $88.4B by 2017

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

ACell Signs National Purchasing Agreement With Novation

Read Now